E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/27/2006 in the Prospect News Biotech Daily.

Neuroscience receives $50 million intent to purchase

By Lisa Kerner

Charlotte, N.C., June 27 - Neuroscience Therapy Corp. said it has received a signed intent-to-purchase tender offer for $50 million.

The company expects to close the transaction within 10 days.

Las Vegas-based Neuroscience specializes in pain relief products.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.